儿童和青少年的分化甲状腺癌:在单一中心12年的经验
Francisca Marques Puga1, Laura Correia2, Inês Vieira3
1Unidade Local de Saúde de Santo António, Serviço de Endocrinologia, Diabetes e Metabolismo, Porto, Portugal
Journal of clinical research in pediatric endocrinology
|April 29, 2024
概括
研究了儿童差异化甲状腺癌 (DTC) 结果. 乳头甲状腺癌 (PTC) 中的淋巴血管侵入与复发风险的增加有关,这表明它在治疗决策中的重要性.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 在瘤学瘤学.
- 手术瘤学手术瘤学
背景情况:
- 分化甲状腺癌 (DTC) 是最常见的儿科内分泌恶性瘤,但研究仍然有限.
- 目前的指导方针建议对DTC进行个性化,基于风险的治疗.
- 淋巴血管侵入是已知的成人风险因素,在儿科DTC管理中经常被忽视.
研究的目的:
- 分析儿科DTC患者的结果.
- 为了确定淋巴血管侵入对DTC持久性或复发风险的影响.
主要方法:
- 在2010-2022年间诊断的21名儿科DTC患者的回顾性分析.
- 评估整个甲状腺切除术,放射性治疗 (RAI) 的使用,以及疾病的持续性/复发性.
- 评估淋巴血管侵袭作为预后因素.
主要成果:
- 乳头甲状腺癌 (PTC) 占病例的81%,52.4%有淋巴血管侵袭.
- 6名患者 (31.6%) 在平均5.7年的随访期间经历了持续性/复发性疾病.
- 患有淋巴血管侵袭的PTC患者的复发率 (55.6%) 与没有 (0.0%,p=0.031) 的患者相比显著更高.
结论:
- 个性化,基于风险的方法对于儿科DTC管理至关重要.
- 淋巴血管侵袭似乎是儿科PTC复发的重要危险因素.
- 建议在儿科PTC治疗决策时考虑淋巴血管侵袭.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


